TELA Bio TELA reported its Q4 earnings results on Thursday, March 21, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
TELA Bio missed estimated earnings by -23.0%, reporting an EPS of $-0.53 versus an estimate of $-0.43.
Revenue was up $5.38 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 19.0% drop in the share price the next day.
Here's a look at TELA Bio's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.49 | -0.53 | -0.56 | -0.55 |
| EPS Actual | -0.45 | -0.46 | -0.63 | -0.52 |
| Revenue Estimate | 16.20M | 14.40M | 12.02M | 13.19M |
| Revenue Actual | 15.05M | 14.49M | 11.91M | 11.62M |
To track all earnings releases for TELA Bio visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
